These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 30898604)

  • 1. Could a nonfunctional adrenal incidentaloma be a risk factor for increased carotid intima-media thickness and metabolic syndrome.
    Emral R; Aydoğan Bİ; Köse AD; Demir Ö; Çorapçıoğlu D
    Endocrinol Diabetes Nutr (Engl Ed); 2019; 66(7):402-409. PubMed ID: 30898604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Could a nonfunctional adrenal incidentaloma be a risk factor for increased carotid intima-media thickness and 10-year cardiovascular mortality based on the SCORE algorithm? A study from a single centre in Poland.
    Szychlińska M; Rzeczkowska M; Matuszewski W; Bandurska-Stankiewicz E
    Endokrynol Pol; 2023; 74(6):. PubMed ID: 37994583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-functioning adrenal incidentalomas are associated with higher hypertension prevalence and higher risk of atherosclerosis.
    Tuna MM; Imga NN; Doğan BA; Yılmaz FM; Topçuoğlu C; Akbaba G; Berker D; Güler S
    J Endocrinol Invest; 2014 Aug; 37(8):765-768. PubMed ID: 24923898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipocytokines in Non-functional Adrenal Incidentalomas and Relation with Insulin Resistance Parameters.
    Akkus G; Evran M; Sert M; Tetiker T
    Endocr Metab Immune Disord Drug Targets; 2019; 19(3):326-332. PubMed ID: 30306882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of Subclinical Cardiovascular Disease in Nonfunctional Adrenal Incidentaloma Patients without Traditional Cardiovascular Risk Factors.
    Cansu GB; Sarı R; Yılmaz N; Özdem S; Çubuk M
    Exp Clin Endocrinol Diabetes; 2017 Jan; 125(1):57-63. PubMed ID: 27684725
    [No Abstract]   [Full Text] [Related]  

  • 6. Carotid Intima-Media Thickness as the Cardiometabolic Risk Indicator in Patients with Nonfunctional Adrenal Mass and Metabolic Syndrome Screening.
    Evran M; Akkuş G; Berk Bozdoğan İ; Gök M; Deniz A; Sert M; Tetiker T
    Med Sci Monit; 2016 Mar; 22():991-7. PubMed ID: 27015815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating E-selectin levels and insulin resistance are associated with early stages of atherosclerosis in nonfunctional adrenal incidentaloma.
    Delibasi T; Karbek B; Bozkurt NC; Cakir E; Gungunes A; Ünsal ÖÖ; Aslan MS; Cakal E
    Arch Endocrinol Metab; 2015 Aug; 59(4):310-7. PubMed ID: 26331318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonfunctioning adrenal incidentaloma: A novel predictive factor for metabolic syndrome.
    Ribeiro Cavalari EM; de Paula MP; Arruda M; Carraro N; Martins A; de Souza K; Coelho MC; de Oliveira E Silva de Morais NA; Moraes AB; Vieira Neto L
    Clin Endocrinol (Oxf); 2018 Nov; 89(5):586-595. PubMed ID: 30044007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
    Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
    Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NEW BIOMARKERS TO PREDICT CARDIOVASCULAR RISK IN PATIENTS WITH ADRENAL INCIDENTALOMA; IRISIN AND NESFATIN-1.
    Can M; Kocabaş M; Karaköse M; Alsancak Y; Yerlikaya FH; Burgucu HC; Cordan I; Kadiyoran C; Kulaksızoğlu M; Karakurt F
    Acta Endocrinol (Buchar); 2022; 18(2):150-155. PubMed ID: 36212257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion.
    Androulakis II; Kaltsas GA; Kollias GE; Markou AC; Gouli AK; Thomas DA; Alexandraki KI; Papamichael CM; Hadjidakis DJ; Piaditis GP
    J Clin Endocrinol Metab; 2014 Aug; 99(8):2754-62. PubMed ID: 24712565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents.
    Pacifico L; Bonci E; Andreoli G; Romaggioli S; Di Miscio R; Lombardo CV; Chiesa C
    Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):737-43. PubMed ID: 24656140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk factors, carotid artery intima media thickness, and HSCRP levels in patients with impaired glucose metabolism.
    Karbek B; Cakal E; Cakir E; Bozkurt N; Unsal I; Sahin M; Delibaşi T
    Minerva Endocrinol; 2013 Sep; 38(3):297-304. PubMed ID: 24126550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence and characteristics of non-functioning and autonomous cortisol secreting adrenal incidentaloma after patients' stratification by body mass index and age.
    Podbregar A; Janez A; Goricar K; Jensterle M
    BMC Endocr Disord; 2020 Jul; 20(1):118. PubMed ID: 32736549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
    Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; Cuesta Hernández M; Sampedro Núñez MA; Marazuela M
    Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uric acid, carotid intima-media thickness and body composition in prepubertal children.
    Bassols J; Martínez-Calcerrada JM; Prats-Puig A; Carreras-Badosa G; Díaz-Roldán F; Osiniri I; Riera-Pérez E; de Zegher F; Ibáñez L; López-Bermejo A
    Pediatr Obes; 2016 Oct; 11(5):375-82. PubMed ID: 26493023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of serum C1q-tumour necrosis factor-related protein 5 levels with metabolic parameters and carotid intima-media thickness in newly diagnosed type 2 diabetes mellitus patients.
    Uçar İMB; Çalan M; Tatar E; Chousein R; Fenercioğlu ÖE; Bozkaya G; Yüksel A
    Hormones (Athens); 2020 Dec; 19(4):559-564. PubMed ID: 32594414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of magnesium supplementation on carotid intima-media thickness and metabolic profiles in diabetic haemodialysis patients: a randomised, double-blind, placebo-controlled trial.
    Talari HR; Zakizade M; Soleimani A; Bahmani F; Ghaderi A; Mirhosseini N; Eslahi M; Babadi M; Mansournia MA; Asemi Z
    Br J Nutr; 2019 Apr; 121(7):809-817. PubMed ID: 30739626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortisol level after dexamethasone suppression test in patients with non-functioning adrenal incidentaloma is positively associated with the duration of reactive hyperemia response on microvascular bed.
    de Paula MP; Moraes AB; de Souza MDGC; Cavalari EMR; Campbell RC; Fernandes GDS; Farias MLF; Mendonça LMC; Madeira M; Bouskela E; Kraemer-Aguiar LG; Vieira Neto L
    J Endocrinol Invest; 2021 Mar; 44(3):609-619. PubMed ID: 32686043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of serum resistin levels with metabolic syndrome and early atherosclerosis in obese Chinese children.
    Chen XY; Zhang JH; Liu F; Liu HM; Song YY; Liu YL
    J Pediatr Endocrinol Metab; 2013; 26(9-10):855-60. PubMed ID: 23729554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.